It's Time For a Quick Look at Cigna's Fundamentals.

By Scott Lee • Friday, November 11 12:00 • Permanent Link

Cigna marked a -10.2% change today, compared to 0.1% for the S&P 500. Is it a good value at today's price of $290.33? Only an in-depth analysis can answer that question, but here are some facts that can give you an idea:

Cigna Corporation provides insurance and related products and services in the United States.
Cigna belongs to the Healthcare sector, which has an average price to earnings (P/E) ratio of 13.21 and an average price to book (P/B) of 4.07
The company's P/B ratio is 2.0
Cigna has a trailing 12 month Price to Earnings (P/E) ratio of 13.9 based on its trailing 12 month price to earnings (Eps) of $20.83 per share
Its forward P/E ratio is 11.7, based on its forward earnings per share (Eps) of $24.85
CI has a Price to Earnings Growth (PEG) ratio of 1.24, which shows the company has a fair value when we factor growth into the price to earnings calculus.
Over the last four years, Cigna has averaged free cash flows of $6,742,500,000.00, which on average grew 45.0%
CI's gross profit margins have averaged 19.6 % over the last four years and during this time they had a growth rate of -23.6 % and a coefficient of variability of 47.7 %.
Cigna has moved 48.5% over the last year compared to -15.5% for the S&P 500 -- a difference of 64.0%
CI has an average analyst rating of buy and is -17.62% away from its mean target price of $352.45 per share

At Market Interference, our mission is to give investors access to timely and accurate data to help them make better investment decisions. subscribe to our free newsletter today to keep track of each day's market movers!

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.